Annual Total Liabilities
$53.14 B
+$14.43 B+37.27%
31 December 2023
Summary:
Eli Lilly and Company annual total liabilities is currently $53.14 billion, with the most recent change of +$14.43 billion (+37.27%) on 31 December 2023. During the last 3 years, it has risen by +$12.33 billion (+30.23%). LLY annual total liabilities is now at all-time high.LLY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$61.29 B
+$3.05 B+5.23%
30 September 2024
Summary:
Eli Lilly and Company quarterly total liabilities is currently $61.29 billion, with the most recent change of +$3.05 billion (+5.23%) on 30 September 2024. Over the past year, it has increased by +$14.68 billion (+31.49%). LLY quarterly total liabilities is now at all-time high.LLY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +37.3% | +31.5% |
| 3 y3 years | +30.2% | +52.3% |
| 5 y5 years | +61.0% | +78.0% |
LLY Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +37.3% | at high | +64.3% |
| 5 y | 5 years | at high | +61.0% | at high | +78.0% |
| alltime | all time | at high | +3635.3% | at high | +4207.7% |
Eli Lilly And Company Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $61.29 B(+5.2%) |
| June 2024 | - | $58.24 B(+14.1%) |
| Mar 2024 | - | $51.05 B(-3.9%) |
| Dec 2023 | $53.14 B(+37.3%) | $53.14 B(+14.0%) |
| Sept 2023 | - | $46.61 B(+6.7%) |
| June 2023 | - | $43.66 B(+4.3%) |
| Mar 2023 | - | $41.87 B(+8.1%) |
| Dec 2022 | $38.71 B(-2.4%) | $38.71 B(+3.8%) |
| Sept 2022 | - | $37.30 B(-2.9%) |
| June 2022 | - | $38.40 B(+2.5%) |
| Mar 2022 | - | $37.46 B(-5.5%) |
| Dec 2021 | $39.65 B(-2.8%) | $39.65 B(-1.4%) |
| Sept 2021 | - | $40.23 B(-2.2%) |
| June 2021 | - | $41.15 B(+3.5%) |
| Mar 2021 | - | $39.74 B(-2.6%) |
| Dec 2020 | $40.81 B(+11.5%) | $40.81 B(+4.8%) |
| Sept 2020 | - | $38.95 B(+3.3%) |
| June 2020 | - | $37.70 B(-0.6%) |
| Mar 2020 | - | $37.91 B(+3.6%) |
| Dec 2019 | $36.59 B(+10.9%) | $36.59 B(+6.3%) |
| Sept 2019 | - | $34.43 B(-3.8%) |
| June 2019 | - | $35.81 B(+1.0%) |
| Mar 2019 | - | $35.44 B(+7.4%) |
| Dec 2018 | $33.00 B(-0.9%) | $33.00 B(+8.3%) |
| Sept 2018 | - | $30.47 B(-0.9%) |
| June 2018 | - | $30.74 B(+3.3%) |
| Mar 2018 | - | $29.77 B(-10.6%) |
| Dec 2017 | $33.31 B(+34.7%) | $33.31 B(+18.8%) |
| Sept 2017 | - | $28.05 B(+4.8%) |
| June 2017 | - | $26.78 B(+13.8%) |
| Mar 2017 | - | $23.52 B(-4.9%) |
| Dec 2016 | $24.73 B(+17.9%) | $24.73 B(+12.5%) |
| Sept 2016 | - | $21.97 B(+0.7%) |
| June 2016 | - | $21.82 B(+11.0%) |
| Mar 2016 | - | $19.66 B(-6.3%) |
| Dec 2015 | $20.98 B(+0.3%) | $20.98 B(-0.4%) |
| Sept 2015 | - | $21.06 B(-1.3%) |
| June 2015 | - | $21.33 B(+3.0%) |
| Mar 2015 | - | $20.71 B(-1.0%) |
| Dec 2014 | $20.92 B(+18.8%) | $20.92 B(+23.3%) |
| Sept 2014 | - | $16.97 B(-0.3%) |
| June 2014 | - | $17.02 B(+3.8%) |
| Mar 2014 | - | $16.41 B(-6.8%) |
| Dec 2013 | $17.61 B(-10.3%) | $17.61 B(+3.2%) |
| Sept 2013 | - | $17.07 B(-5.1%) |
| June 2013 | - | $17.99 B(+3.7%) |
| Mar 2013 | - | $17.34 B(-11.6%) |
| Dec 2012 | $19.63 B(-2.5%) | $19.63 B(+7.5%) |
| Sept 2012 | - | $18.26 B(+4.3%) |
| June 2012 | - | $17.50 B(+0.5%) |
| Mar 2012 | - | $17.42 B(-13.5%) |
| Dec 2011 | $20.12 B(+8.3%) | $20.12 B(+11.9%) |
| Sept 2011 | - | $17.98 B(-2.8%) |
| June 2011 | - | $18.50 B(+4.2%) |
| Mar 2011 | - | $17.76 B(-4.5%) |
| Dec 2010 | $18.59 B(+3.6%) | $18.59 B(+6.3%) |
| June 2010 | - | $17.49 B(+4.5%) |
| Mar 2010 | - | $16.74 B(-6.7%) |
| Dec 2009 | $17.94 B(-20.2%) | $17.94 B(+4.1%) |
| Sept 2009 | - | $17.22 B(-6.3%) |
| June 2009 | - | $18.37 B(-2.7%) |
| Mar 2009 | - | $18.87 B(-16.0%) |
| Dec 2008 | $22.47 B(+68.1%) | $22.47 B(+60.9%) |
| Sept 2008 | - | $13.97 B(+7.3%) |
| June 2008 | - | $13.01 B(+5.7%) |
| Mar 2008 | - | $12.31 B(-7.9%) |
| Dec 2007 | $13.37 B(+21.8%) | $13.37 B(+11.2%) |
| Sept 2007 | - | $12.03 B(-3.8%) |
| June 2007 | - | $12.50 B(+2.4%) |
| Mar 2007 | - | $12.20 B(+11.2%) |
| Dec 2006 | $10.97 B | $10.97 B(+1.1%) |
| Sept 2006 | - | $10.86 B(-13.2%) |
| June 2006 | - | $12.51 B(+0.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2006 | - | $12.45 B(-9.7%) |
| Dec 2005 | $13.79 B(-1.1%) | $13.79 B(+2.7%) |
| Sept 2005 | - | $13.42 B(+2.0%) |
| June 2005 | - | $13.15 B(+13.0%) |
| Mar 2005 | - | $11.64 B(-16.5%) |
| Dec 2004 | $13.95 B(+17.0%) | $13.95 B(+8.3%) |
| Sept 2004 | - | $12.88 B(+4.9%) |
| June 2004 | - | $12.27 B(+3.6%) |
| Mar 2004 | - | $11.84 B(-0.7%) |
| Dec 2003 | $11.92 B(+10.7%) | $11.92 B(+5.4%) |
| Sept 2003 | - | $11.32 B(-0.4%) |
| June 2003 | - | $11.37 B(+4.1%) |
| Mar 2003 | - | $10.91 B(+1.4%) |
| Dec 2002 | $10.77 B(+15.4%) | $10.77 B(+1.0%) |
| Sept 2002 | - | $10.66 B(+8.8%) |
| June 2002 | - | $9.80 B(+4.7%) |
| Mar 2002 | - | $9.36 B(+0.3%) |
| Dec 2001 | $9.33 B(+7.9%) | $9.33 B(+3.3%) |
| Sept 2001 | - | $9.03 B(+1.8%) |
| June 2001 | - | $8.87 B(+8.7%) |
| Mar 2001 | - | $8.16 B(-5.6%) |
| Dec 2000 | $8.64 B(+10.6%) | $8.64 B(+14.9%) |
| Sept 2000 | - | $7.52 B(+0.1%) |
| June 2000 | - | $7.52 B(+6.8%) |
| Mar 2000 | - | $7.04 B(-9.9%) |
| Dec 1999 | $7.81 B(-4.3%) | $7.81 B(+4.7%) |
| Sept 1999 | - | $7.46 B(+17.2%) |
| June 1999 | - | $6.37 B(+0.1%) |
| Mar 1999 | - | $6.37 B(-22.0%) |
| Dec 1998 | $8.17 B(+5.1%) | $8.17 B(+3.2%) |
| Sept 1998 | - | $7.91 B(+12.0%) |
| June 1998 | - | $7.07 B(-0.4%) |
| Mar 1998 | - | $7.09 B(-8.7%) |
| Dec 1997 | $7.77 B(-5.3%) | $7.77 B(+4.6%) |
| Sept 1997 | - | $7.43 B(-2.5%) |
| June 1997 | - | $7.62 B(-4.1%) |
| Mar 1997 | - | $7.94 B(-3.2%) |
| Dec 1996 | $8.21 B(-8.6%) | $8.21 B(+2.3%) |
| Sept 1996 | - | $8.03 B(-4.1%) |
| June 1996 | - | $8.37 B(+0.6%) |
| Mar 1996 | - | $8.31 B(-7.4%) |
| Dec 1995 | $8.98 B(-1.9%) | $8.98 B(+2.5%) |
| Sept 1995 | - | $8.77 B(-3.9%) |
| June 1995 | - | $9.12 B(-0.0%) |
| Mar 1995 | - | $9.13 B(-0.3%) |
| Dec 1994 | $9.15 B(+81.1%) | $9.15 B(+76.2%) |
| Sept 1994 | - | $5.19 B(+3.3%) |
| June 1994 | - | $5.03 B(+3.3%) |
| Mar 1994 | - | $4.87 B(-3.7%) |
| Dec 1993 | $5.05 B(+33.7%) | $5.05 B(+31.2%) |
| Sept 1993 | - | $3.85 B(+2.9%) |
| June 1993 | - | $3.74 B(-2.3%) |
| Mar 1993 | - | $3.83 B(+1.4%) |
| Dec 1992 | $3.78 B(+13.4%) | $3.78 B(+2.1%) |
| Sept 1992 | - | $3.70 B(+15.3%) |
| June 1992 | - | $3.21 B(+3.1%) |
| Mar 1992 | - | $3.11 B(-6.6%) |
| Dec 1991 | $3.33 B(-9.3%) | $3.33 B(+10.3%) |
| Sept 1991 | - | $3.02 B(+11.3%) |
| June 1991 | - | $2.71 B(+4.1%) |
| Mar 1991 | - | $2.61 B(-29.1%) |
| Dec 1990 | $3.68 B(+75.8%) | $3.68 B(+11.9%) |
| Sept 1990 | - | $3.28 B(+31.9%) |
| June 1990 | - | $2.49 B(+24.2%) |
| Mar 1990 | - | $2.00 B(-4.1%) |
| Dec 1989 | $2.09 B(+2.6%) | $2.09 B(+6.9%) |
| Sept 1989 | - | $1.96 B(+5.6%) |
| June 1989 | - | $1.85 B(-9.1%) |
| Dec 1988 | $2.04 B(-7.9%) | $2.04 B(-7.9%) |
| Dec 1987 | $2.21 B(+19.2%) | $2.21 B(+19.2%) |
| Dec 1986 | $1.86 B(+18.5%) | $1.86 B(+18.5%) |
| Dec 1985 | $1.57 B(+10.1%) | $1.57 B(+10.1%) |
| Dec 1984 | $1.42 B | $1.42 B |
FAQ
- What is Eli Lilly and Company annual total liabilities?
- What is the all time high annual total liabilities for Eli Lilly and Company?
- What is Eli Lilly and Company annual total liabilities year-on-year change?
- What is Eli Lilly and Company quarterly total liabilities?
- What is the all time high quarterly total liabilities for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly total liabilities year-on-year change?
What is Eli Lilly and Company annual total liabilities?
The current annual total liabilities of LLY is $53.14 B
What is the all time high annual total liabilities for Eli Lilly and Company?
Eli Lilly and Company all-time high annual total liabilities is $53.14 B
What is Eli Lilly and Company annual total liabilities year-on-year change?
Over the past year, LLY annual total liabilities has changed by +$14.43 B (+37.27%)
What is Eli Lilly and Company quarterly total liabilities?
The current quarterly total liabilities of LLY is $61.29 B
What is the all time high quarterly total liabilities for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly total liabilities is $61.29 B
What is Eli Lilly and Company quarterly total liabilities year-on-year change?
Over the past year, LLY quarterly total liabilities has changed by +$14.68 B (+31.49%)